Antidepressant treatment and global tests of coagulation and fibrinolysis [6]

Journal of Clinical Psychiatry

Volumn 62, Issue 2, 2001, Pages 130-

  Lederbogen, F ^a   Weber, B ^a   Colla, M ^a   Heuser, I ^a   Deuschle, M ^a   Dempfle, C E ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; FIBRIN MONOMER; FIBRINOGEN; PAROXETINE; PLACEBO; PROTHROMBIN; THROMBOPLASTIN; TRICYCLIC ANTIDEPRESSANT AGENT; VON WILLEBRAND FACTOR;

ADULT; AGED; BLEEDING; BLOOD ANALYSIS; BLOOD CLOTTING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FEMALE; FIBRINOLYSIS; HUMAN; LETTER; MALE; PRIORITY JOURNAL; RATING SCALE; THROMBOPLASTIN TIME;

EID: 0035102152     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v62n0210g     Document Type: Letter

References (6)

1. Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors
2. Fluoxetine and hemostatic function: A pilot study
3. Effect of fluoxetine on prothrombin time
4. Effect of sertraline on protein binding of warfarin
5. Unstable anticoagulation in the course of amitriptyline treatment
6. Exaggerated platelet reactivity in major depression